268 related articles for article (PubMed ID: 28424902)
1. Physical and psychosocial aspects of adolescent and young adults after allogeneic hematopoietic stem-cell transplantation: results from a prospective multicenter trial.
Pulewka K; Wolff D; Herzberg PY; Greinix H; Heussner P; Mumm FHA; von Harsdorf S; Rieger K; Hemmati P; Hochhaus A; Hilgendorf I
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1613-1619. PubMed ID: 28424902
[TBL] [Abstract][Full Text] [Related]
2. Personality influences quality-of-life assessments in adult patients after allogeneic hematopoietic SCT: results from a joint evaluation of the prospective German Multicenter Validation Trial and the Fred Hutchinson Cancer Research Center.
Herzberg PY; Lee SJ; Heussner P; Mumm FH; Hilgendorf I; von Harsdorf S; Hemmati P; Rieger K; Greinix HT; Freund M; Holler E; Wolff D
Bone Marrow Transplant; 2013 Jan; 48(1):129-34. PubMed ID: 22609882
[TBL] [Abstract][Full Text] [Related]
3. Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation.
Herzberg PY; Heussner P; Mumm FH; Horak M; Hilgendorf I; von Harsdorf S; Hemmati P; Rieger K; Greinix H; Freund M; Lee SJ; Holler E; Wolff D
Biol Blood Marrow Transplant; 2010 Dec; 16(12):1707-17. PubMed ID: 20541028
[TBL] [Abstract][Full Text] [Related]
4. Quality-of-Life Trajectories in Adolescent and Young Adult versus Older Adult Allogeneic Hematopoietic Cell Transplantation Recipients.
Mathanda RR; Hamilton BK; Rybicki L; Advani AS; Colver A; Dabney J; Ferraro C; Hanna R; Kalaycio M; Lawrence C; McLellan L; Sobecks R; Majhail NS; Rotz SJ
Biol Blood Marrow Transplant; 2020 Aug; 26(8):1505-1510. PubMed ID: 32439476
[TBL] [Abstract][Full Text] [Related]
5. Clinical, social, and psycho-oncological needs of adolescents and young adults (AYA) versus older patients following hematopoietic stem cell transplantation.
Pulewka K; Strauss B; Hochhaus A; Hilgendorf I
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1239-1246. PubMed ID: 33052515
[TBL] [Abstract][Full Text] [Related]
6. Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation.
Pallua S; Giesinger J; Oberguggenberger A; Kemmler G; Nachbaur D; Clausen J; Kopp M; Sperner-Unterweger B; Holzner B
Bone Marrow Transplant; 2010 Oct; 45(10):1534-9. PubMed ID: 20228854
[TBL] [Abstract][Full Text] [Related]
7. Psychosocial care for adolescent and young adult hematopoietic cell transplant patients.
Cooke L; Chung C; Grant M
J Psychosoc Oncol; 2011; 29(4):394-414. PubMed ID: 21966725
[TBL] [Abstract][Full Text] [Related]
8. Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease.
El-Jawahri A; Pidala J; Inamoto Y; Chai X; Khera N; Wood WA; Cutler C; Arora M; Carpenter PA; Palmer J; Flowers M; Weisdorf D; Pavletic S; Jaglowski S; Jagasia M; Lee SJ; Chen YB
Biol Blood Marrow Transplant; 2014 Sep; 20(9):1341-8. PubMed ID: 24813171
[TBL] [Abstract][Full Text] [Related]
9. Impact of outpatient non-myeloablative haematopoietic stem cell transplantation in quality of life vs. conventional therapy.
Cantú-Rodríguez OG; Sánchez-Cárdenas M; Treviño-Montemayor OR; Gutiérrez-Aguirre CH; Tarín-Arzaga L; Jaime-Pérez JC; Gómez-Almaguer D
Psychol Health Med; 2016; 21(1):10-9. PubMed ID: 26125120
[TBL] [Abstract][Full Text] [Related]
10. [Impact of the type of hematopoietic stem-cell transplant on quality of life and psychopathology].
Janicsák H; Masszi T; Reményi P; Ungvari GS; Gazdag G
Ideggyogy Sz; 2023 Jan; 76(1-2):25-35. PubMed ID: 36892298
[TBL] [Abstract][Full Text] [Related]
11. High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning.
Reshef R; Huffman AP; Gao A; Luskin MR; Frey NV; Gill SI; Hexner EO; Kambayashi T; Loren AW; Luger SM; Mangan JK; Nasta SD; Richman LP; Sell M; Stadtmauer EA; Vonderheide RH; Mick R; Porter DL
J Clin Oncol; 2015 Jul; 33(21):2392-8. PubMed ID: 26056179
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with social functioning among long-term cancer survivors treated with hematopoietic stem cell transplantation as adolescents or young adults.
Walsh CA; Yi JC; Rosenberg AR; Crouch MV; Leisenring WM; Syrjala KL
Psychooncology; 2020 Oct; 29(10):1579-1586. PubMed ID: 32628342
[TBL] [Abstract][Full Text] [Related]
13. Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease.
Kurosawa S; Oshima K; Yamaguchi T; Yanagisawa A; Fukuda T; Kanamori H; Mori T; Takahashi S; Kondo T; Kohno A; Miyamura K; Umemoto Y; Teshima T; Taniguchi S; Yamashita T; Inamoto Y; Kanda Y; Okamoto S; Atsuta Y
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1749-1758. PubMed ID: 28669922
[TBL] [Abstract][Full Text] [Related]
14. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
[TBL] [Abstract][Full Text] [Related]
15. Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study.
Sun CL; Kersey JH; Francisco L; Armenian SH; Baker KS; Weisdorf DJ; Forman SJ; Bhatia S
Biol Blood Marrow Transplant; 2013 Jul; 19(7):1073-80. PubMed ID: 23583827
[TBL] [Abstract][Full Text] [Related]
16. Low non-relapse mortality and long-term preserved quality of life in older patients undergoing matched related donor allogeneic stem cell transplantation: a prospective multicenter phase II trial.
Blaise D; Devillier R; Lecoroller-Sorriano AG; Boher JM; Boyer-Chammard A; Tabrizi R; Chevallier P; Fegueux N; Sirvent A; Michallet M; Bay JO; Fürst S; El-Cheikh J; Vincent L; Guillaume T; Regny C; Milpied N; Castagna L; Mohty M
Haematologica; 2015 Feb; 100(2):269-74. PubMed ID: 25425691
[TBL] [Abstract][Full Text] [Related]
17. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
18. Neurologic complications after allogeneic hematopoietic stem cell transplantation in children: analysis of prognostic factors.
Kang JM; Kim YJ; Kim JY; Cho EJ; Lee JH; Lee MH; Lee SH; Sung KW; Koo HH; Yoo KH
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1091-8. PubMed ID: 25708217
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
[TBL] [Abstract][Full Text] [Related]
20. Validation of the grip test and human activity profile for evaluation of physical performance during the intermediate phase after allogeneic hematopoietic stem cell transplantation.
Kramer M; Heussner P; Herzberg PY; Andree H; Hilgendorf I; Leithaeuser M; Junghanss C; Freund M; Wolff D
Support Care Cancer; 2013 Apr; 21(4):1121-9. PubMed ID: 23111942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
